Regulatory frameworks for genetically modified organisms differ markedly across jurisdictions, reflecting divergent public attitudes, legal traditions, and approaches to risk management. The three major regulatory models are process-based (EU), product-based (US), and hybrid approaches (Japan, Australia, Brazil). These frameworks govern the approval process for cultivation and import of GM crops, labeling requirements for GM foods, traceability systems, and the management of adventitious presence of unauthorized GM material in the food supply.
The European Union operates under a stringent process-based regulatory system. Regulation (EC) 1829/2003 governs the authorization of GM food and feed, requiring a scientific risk assessment by EFSA followed by a political decision by the European Commission and Member States. Labeling is mandatory for all food and feed products containing or consisting of GM organisms above a threshold of 0.9% for authorized events. The labeling requirement applies regardless of detectability in the final product, covering highly refined oils and starches from GM crops. Regulation (EC) 1830/2003 establishes traceability requirements along the entire supply chain.
The United States follows a product-based approach under the Coordinated Framework for Regulation of Biotechnology, implemented through the FDA, USDA-APHIS, and EPA. The FDA’s biotechnology consultation process evaluates the safety of foods derived from GM crops on a voluntary basis, though all commercialized GM varieties have undergone this process. The National Bioengineered Food Disclosure Standard (NBFDS), effective 2022, requires labeling of bioengineered foods using text, symbol, or electronic link. The standard defines bioengineered food as containing genetic material modified through in vitro rDNA techniques, excluding highly refined products where modified DNA is undetectable.
Other major regulatory regimes include Japan’s mandatory labeling system with a 5% threshold for authorized GM events, Australia and New Zealand’s FSANZ assessment with mandatory labeling for novel DNA or protein, and Brazil’s comprehensive framework modeled partly on the EU system. The Cartagena Protocol on Biosafety, an international treaty under the Convention on Biological Diversity, governs the transboundary movement, transit, handling, and use of living modified organisms. Adventitious presence of unauthorized GM events in imported commodities remains a significant trade issue, with zero-tolerance policies in some jurisdictions causing supply chain disruptions. Regulatory frameworks govern the approval of GM foods and are informed by safety assessment data. Enforcement relies on detection methods to verify compliance with labeling thresholds.
